We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

194 hedge funds and large institutions have $1.99B invested in Amedisys in 2018 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 64 increasing their positions, 69 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 26

14% more capital invested

Capital invested by funds: $1.74B → $1.99B (+$251M)

3% more funds holding

Funds holding: 188194 (+6)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.2% less ownership

Funds ownership: 97.44%97.24% (-0.2%)

7% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 69

25% less call options, than puts

Call options by funds: $3.36M | Put options by funds: $4.5M

Holders
194
Holders Change
+6
Holders Change %
+3.19%
% of All Funds
4.45%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
35
Increased
64
Reduced
69
Closed
26
Calls
$3.36M
Puts
$4.5M
Net Calls
-$1.14M
Net Calls Change
-$1.82M
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$14.3M +$321K +5,632 +2%
O
27
OrbiMed
New York
$12.5M
EOJOAM
28
E. Ohman J:or Asset Management
Sweden
$11.8M +$1.75M +30,785 +19%
Charles Schwab
29
Charles Schwab
California
$11.2M +$541K +9,506 +5%
CAM
30
Cortina Asset Management
Wisconsin
$10.6M +$10M +175,970 New
Deutsche Bank
31
Deutsche Bank
Germany
$10.5M +$5.38M +94,519 +119%
TCM
32
Tygh Capital Management
Oregon
$9M +$1.95M +34,207 +30%
Bank of America
33
Bank of America
North Carolina
$8.98M +$2.41M +42,263 +40%
SI
34
Sapience Investments
California
$8.67M +$79.7K +1,400 +1%
Invesco
35
Invesco
Georgia
$8.57M +$2.08M +36,490 +35%
Man Group
36
Man Group
United Kingdom
$7.93M +$7.49M +131,416 New
TCIM
37
TIAA CREF Investment Management
New York
$7.75M -$48.4K -850 -0.7%
GLA
38
Great Lakes Advisors
Illinois
$7.73M +$2.03M +35,611 +38%
HW
39
Hancock Whitney
Mississippi
$7.7M +$211K +3,701 +3%
PCM
40
Peregrine Capital Management
Minnesota
$7.31M +$6.9M +121,111 New
AllianceBernstein
41
AllianceBernstein
Tennessee
$6.72M +$1.36M +23,900 +27%
Morgan Stanley
42
Morgan Stanley
New York
$5.69M +$360K +6,312 +7%
TA
43
Teachers Advisors
New York
$4.88M +$5.07K +89 +0.1%
Federated Hermes
44
Federated Hermes
Pennsylvania
$4.71M +$4.34M +76,176 +3,988%
Acadian Asset Management
45
Acadian Asset Management
Massachusetts
$4.65M +$1.45M +25,489 +49%
CAM
46
ClariVest Asset Management
California
$4.65M +$11.4K +200 +0.3%
PPA
47
Parametric Portfolio Associates
Washington
$4.62M -$28.9K -507 -0.7%
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$4.53M +$4.27M +75,000 New
ZIM
49
Zacks Investment Management
Illinois
$4.51M +$4.26M +74,785 New
New York State Teachers Retirement System (NYSTRS)
50
New York State Teachers Retirement System (NYSTRS)
New York
$4.5M -$148K -2,600 -3%

AMED Hedge Fund Activity: Q1 2018 in Review

194 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2018, worth a combined $1.99B — up 14% from $1.74B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new AMED positions and 26 closed out — a net gain of 9 holders — while 64 added to existing stakes and 69 trimmed.

The largest buyer was Ameriprise, adding an estimated $34.9M. The largest seller was Millennium Management, cutting an estimated $45.5M.

  • 194 institutional investors held Amedisys (AMED) as of Q1 2018, up from 188 in Q4 2017.
  • Funds reported $1.99B of Amedisys stock for Q1 2018, up 14% quarter-over-quarter.
  • 35 funds opened new Amedisys positions in Q1 2018 and 26 closed out, a net change of +9 holders.
  • The largest Amedisys buyer in Q1 2018 was Ameriprise, an estimated $34.9M added.
  • The largest Amedisys seller in Q1 2018 was Millennium Management, an estimated $45.5M sold.

Based on aggregated 13F filings for Q1 2018.